Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Change in Other Operating Liabilities (2024 - 2025)

Updated

Analysis

Impact Biomedical (IBO) Change in Other Operating Liabilities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,148.60 Bn 1,117.19 Bn 19.71 Bn -
2 Johnson & Johnson 637.24 Bn 557.10 Bn 17.30 Bn 2.69 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn -
4 Merck 356.72 Bn 311.10 Bn 12.21 Bn -
5 Novartis Ag 301.65 Bn 265.64 Bn 11.24 Bn -
6 Astrazeneca 265.03 Bn 238.72 Bn 12.86 Bn -
7 Amgen 239.14 Bn 194.54 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.82 Bn 169.02 Bn 6.22 Bn -
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -112.00 Mn
10 Impact Biomedical 409.72 Mn 412.92 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 271,000.00
Mar 31, 2024 230,000.00
API Access

Impact Biomedical Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=IBO&period=max&api_key=YOUR_API_KEY